Signal active
Bio
Dr. Tormo has been co-founder and advisor for several biotech companies. Among these companies, he co-founded and was CEO of Bioncotech Therapeutics, a spin-off from the Spanish National Cancer Research Center (CNIO), Restaura Biotech SL (a Polytechnic University of Valencia spin-off), Frozen Shard SL and Polymer Therapeutic Solutions SL. He is also co-founder and partner of Biocapital Advisors SL.
Dr. Tormo holds a BSc from the University of Valencia, Spain, a PhD in Immunology and Molecular Genetics from the University of Bonn, Germany, and a master’s degree in biotechnology management (MBM) from IE Business School, Madrid. He was a post-doc fellow at the University of Michigan. Additionally, he has extensive scientific experience endorsed by scientific publications in prestigious journals. He has recieved scholarships and different awards related to innovation and entrepreneurship such as MIT’s TR35 Spain 2011, Emprendedores sXXI from La Caixa and the Biogen-Idec Foundation award.
Location
Valencia, Comunidad Valenciana, Spain, Europe
Social
Primary Organization
2013
1-10
Biotechnology, Health Care, Biopharma, Therapeutics
Jobs history
6
Minoryx Therapeutics
Board Member
2022 - Current
Integra Therapeutics
Board of Directors
2022 - Current
Highlight Therapeutics
Co-Founder
2013 - Current
Columbus Venture Partners
General Partner
2016 - Current
Highlight Therapeutics
Board Member
2013 - Current
Fundación Columbus
President & Patron
2017 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Damià Tormo is the Chief Executive Officer at Artax Biopharma, based in Europe. With a background in Biotechnology, Damià Tormo has a rich history of leadership and innovation. Damià Tormo studied Master Biotechnology management @ IE Business School. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
1
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
6
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
Mar 29, 2022 | Integra Therapeutics | Seed Round - Integra Therapeutics | Columbus Venture Partners | 1.7M |
May 11, 2022 | Artax Biopharma | Venture Round - Artax Biopharma | Columbus Venture Partners | 26.0M |
May 31, 2022 | Minoryx Therapeutics | Series C - Minoryx Therapeutics | Columbus Venture Partners | 54.7M |
Aug 06, 2024 | Artax Biopharma | Convertible Note - Artax Biopharma | Columbus Venture Partners | 8.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.